Myeloproliferative Neoplasms: Molecular Drivers and Therapeutics.

Abstract excerpt

Activating mutations in genes that drive neoplastic cell growth are numerous and widespread in cancer, and specific genetic alterations are associated with certain types of cancer. For example, classic myeloproliferative neoplasms (MPNs) are hematopoietic stem cell disorders that affect cells of the myeloid lineage, including erythrocytes, platelets, and granulocytes. An activating mutation in the JAK2 tyrosine...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to JAK2 gene
• Share to Molecular Targeted Therapy
• Share to Mutation